vs

Side-by-side financial comparison of Bit Digital, Inc (BTBT) and REGENXBIO Inc. (RGNX). Click either name above to swap in a different company.

Bit Digital, Inc is the larger business by last-quarter revenue ($32.3M vs $30.3M, roughly 1.1× REGENXBIO Inc.). REGENXBIO Inc. runs the higher net margin — -221.3% vs -582.6%, a 361.2% gap on every dollar of revenue. REGENXBIO Inc. produced more free cash flow last quarter ($-52.8M vs $-574.9M).

Digital Equipment Corporation, using the trademark Digital, was a major American company in the computer industry from the 1960s to the 1990s. The company was co-founded by Ken Olsen and Harlan Anderson in 1957. Olsen was president until he was forced to resign in 1992, after the company had gone into precipitous decline.

REGENXBIO Inc. is a clinical-stage biotechnology firm focused on gene therapy for rare severe genetic diseases. It licenses its proprietary AAV vector technology to global biopharma partners, and advances its own pipeline targeting ophthalmology, metabolic and neurodegenerative disorders.

BTBT vs RGNX — Head-to-Head

Bigger by revenue
BTBT
BTBT
1.1× larger
BTBT
$32.3M
$30.3M
RGNX
Higher net margin
RGNX
RGNX
361.2% more per $
RGNX
-221.3%
-582.6%
BTBT
More free cash flow
RGNX
RGNX
$522.1M more FCF
RGNX
$-52.8M
$-574.9M
BTBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTBT
BTBT
RGNX
RGNX
Revenue
$32.3M
$30.3M
Net Profit
$-188.4M
$-67.1M
Gross Margin
Operating Margin
-597.0%
-190.0%
Net Margin
-582.6%
-221.3%
Revenue YoY
43.0%
Net Profit YoY
-31.2%
EPS (diluted)
$-0.53
$-1.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTBT
BTBT
RGNX
RGNX
Q4 25
$32.3M
$30.3M
Q3 25
$30.5M
$29.7M
Q2 25
$25.7M
$21.4M
Q1 25
$25.1M
$89.0M
Q4 24
$21.2M
Q3 24
$24.2M
Q2 24
$22.3M
Q1 24
$15.6M
Net Profit
BTBT
BTBT
RGNX
RGNX
Q4 25
$-188.4M
$-67.1M
Q3 25
$150.9M
$-61.9M
Q2 25
$14.9M
$-70.9M
Q1 25
$-57.7M
$6.1M
Q4 24
$-51.2M
Q3 24
$-59.6M
Q2 24
$-53.0M
Q1 24
$-63.3M
Gross Margin
BTBT
BTBT
RGNX
RGNX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
70.2%
Q3 24
48.8%
Q2 24
52.5%
Q1 24
72.6%
Operating Margin
BTBT
BTBT
RGNX
RGNX
Q4 25
-597.0%
-190.0%
Q3 25
-176.3%
Q2 25
45.7%
-296.3%
Q1 25
-208.6%
13.6%
Q4 24
-242.1%
Q3 24
-256.6%
Q2 24
-251.3%
Q1 24
-408.8%
Net Margin
BTBT
BTBT
RGNX
RGNX
Q4 25
-582.6%
-221.3%
Q3 25
495.3%
-208.3%
Q2 25
58.0%
-331.8%
Q1 25
-229.9%
6.8%
Q4 24
-241.3%
Q3 24
-246.3%
Q2 24
-237.7%
Q1 24
-405.4%
EPS (diluted)
BTBT
BTBT
RGNX
RGNX
Q4 25
$-0.53
$-1.30
Q3 25
$0.47
$-1.20
Q2 25
$0.07
$-1.38
Q1 25
$-0.32
$0.12
Q4 24
$-0.99
Q3 24
$-1.17
Q2 24
$-1.05
Q1 24
$-1.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTBT
BTBT
RGNX
RGNX
Cash + ST InvestmentsLiquidity on hand
$118.4M
$230.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.0M
$102.7M
Total Assets
$1.2B
$453.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTBT
BTBT
RGNX
RGNX
Q4 25
$118.4M
$230.1M
Q3 25
$179.1M
$274.2M
Q2 25
$181.2M
$323.3M
Q1 25
$57.6M
$267.9M
Q4 24
$234.7M
Q3 24
$255.5M
Q2 24
$290.4M
Q1 24
$338.7M
Stockholders' Equity
BTBT
BTBT
RGNX
RGNX
Q4 25
$724.0M
$102.7M
Q3 25
$906.2M
$161.5M
Q2 25
$633.2M
$213.7M
Q1 25
$417.4M
$274.2M
Q4 24
$259.7M
Q3 24
$301.4M
Q2 24
$348.3M
Q1 24
$390.7M
Total Assets
BTBT
BTBT
RGNX
RGNX
Q4 25
$1.2B
$453.0M
Q3 25
$1.1B
$525.2M
Q2 25
$723.4M
$581.0M
Q1 25
$485.2M
$490.9M
Q4 24
$466.0M
Q3 24
$519.1M
Q2 24
$569.4M
Q1 24
$629.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTBT
BTBT
RGNX
RGNX
Operating Cash FlowLast quarter
$-288.9M
$-52.3M
Free Cash FlowOCF − Capex
$-574.9M
$-52.8M
FCF MarginFCF / Revenue
-1778.0%
-174.0%
Capex IntensityCapex / Revenue
884.4%
1.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-943.7M
$-126.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTBT
BTBT
RGNX
RGNX
Q4 25
$-288.9M
$-52.3M
Q3 25
$-240.0M
$-56.0M
Q2 25
$17.7M
$-49.3M
Q1 25
$17.4M
$33.6M
Q4 24
$-31.6M
Q3 24
$-40.5M
Q2 24
$-45.5M
Q1 24
$-55.5M
Free Cash Flow
BTBT
BTBT
RGNX
RGNX
Q4 25
$-574.9M
$-52.8M
Q3 25
$-256.8M
$-56.5M
Q2 25
$-64.5M
$-49.7M
Q1 25
$-47.6M
$32.6M
Q4 24
$-32.7M
Q3 24
$-40.9M
Q2 24
$-46.0M
Q1 24
$-56.0M
FCF Margin
BTBT
BTBT
RGNX
RGNX
Q4 25
-1778.0%
-174.0%
Q3 25
-843.1%
-189.9%
Q2 25
-251.3%
-232.8%
Q1 25
-189.4%
36.6%
Q4 24
-154.2%
Q3 24
-168.9%
Q2 24
-206.2%
Q1 24
-358.5%
Capex Intensity
BTBT
BTBT
RGNX
RGNX
Q4 25
884.4%
1.7%
Q3 25
55.4%
1.7%
Q2 25
320.3%
1.8%
Q1 25
258.8%
1.2%
Q4 24
5.1%
Q3 24
1.3%
Q2 24
2.1%
Q1 24
3.6%
Cash Conversion
BTBT
BTBT
RGNX
RGNX
Q4 25
Q3 25
-1.59×
Q2 25
1.19×
Q1 25
5.53×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTBT
BTBT

Cloud Services$19.3M60%
Digital Asset Mining$5.5M17%
Colocation Services$3.8M12%
Other$3.7M11%

RGNX
RGNX

Novartis Gene Therapies$24.2M80%
Nippon Shinyaku Collaboration And License Agreement$4.3M14%
Nippon Shinyaku Services$1.4M5%

Related Comparisons